invas
infect
human
caus
wide
varieti
protozoan
fungal
microbi
viral
pathogen
render
microbiolog
viral
diagnosi
complic
task
especi
sinc
mani
pathogen
gener
similar
sometim
even
ident
clinic
syndrom
complic
factor
clinic
sampl
submit
culturebas
diagnost
procedur
frequent
contamin
microorgan
natur
colon
epitheli
line
human
bodi
moreov
specimen
also
may
contain
substanc
limit
chanc
pathogen
surviv
therebi
cultiv
success
whole
microbi
diagnost
usual
perform
wide
varieti
clinic
sampl
microbi
agent
requir
identif
may
differ
preval
age
sex
habit
demograph
health
statu
sever
person
characterist
individu
patient
preval
infecti
agent
may
also
subject
strong
season
geograph
variat
current
consid
strongli
influenc
travel
habit
well
cultureori
clinic
microbiolog
seem
art
rather
precis
scientif
approach
respect
correct
diagnosi
much
depend
expertis
clinic
microbiologist
infecti
diseas
id
specialist
diagnost
procedur
sever
import
decis
must
taken
may
bias
due
person
prefer
rather
scientif
appropri
choic
microbiolog
laboratori
procedur
usual
dictat
person
experi
doctor
ask
specif
type
diagnost
assay
may
alway
obviou
one
clinic
paramet
assess
bedsid
first
step
microbi
diagnosi
normal
consist
straightforward
gram
stain
procedur
segreg
gramposit
gramneg
bacteria
alreadi
part
may
lead
direct
speci
identif
pathogen
involv
malaria
parasit
instanc
show
distinct
morpholog
featur
upon
simpl
giemsa
stain
blood
smear
iqbal
et
al
subsequ
clinic
specimen
may
analyz
cultivationbas
test
addit
concomit
host
serum
sampl
may
analyz
antibodi
rais
host
immun
system
pathogen
involv
microbi
antigen
rather
complet
viabl
organ
search
well
final
investig
finish
pathogen
identifi
beyond
reason
doubt
ration
therapi
implement
avail
therapi
usual
preced
assess
antimicrobi
suscept
profil
virul
characterist
microorgan
involv
case
success
cultiv
cours
goe
without
say
speed
qualiti
diagnost
procedur
end
determin
clinic
impact
efficaci
antibiot
therapi
sinc
pathogen
may
transmit
easili
human
diagnosi
import
also
relev
keep
track
spread
certain
pathogen
hospit
open
popul
classic
microbiolog
use
method
phagetyp
serotyp
antibiogram
comparison
assess
epidemiolog
related
among
strain
given
pathogen
speci
diagnost
epidemiolog
method
mention
place
alreadi
quit
time
see
continu
impact
infecti
diseas
modern
societi
ie
aid
pandem
biolog
warfar
emerg
multidrug
resist
bacteria
recent
sar
outbreak
persist
need
continu
improv
diagnost
microbiolog
virolog
demain
initi
serolog
test
cover
host
antibodi
respons
assess
bacteri
serotyp
help
improv
adequ
diagnosi
sever
infecti
diseas
recent
molecular
microbiolog
provid
laboratori
addit
tool
help
significantli
improv
qualiti
microbi
detect
subspeci
identif
see
fig
molecular
microbiolog
techniqu
initi
develop
fundament
research
laboratori
direct
result
past
one
two
decad
identif
organ
infecti
human
greatli
facilit
develop
applic
specif
molecular
hybrid
probe
test
ksiazek
et
al
addit
avail
realtim
nucleic
acid
amplif
method
instrument
develop
anoth
even
recent
categori
direct
highli
sensit
diagnost
assay
polymeras
chain
reaction
pcr
among
popular
method
wolk
et
al
current
avail
molecular
assay
enabl
direct
detect
antigen
dna
rna
put
pathogen
clinic
materi
genet
identif
also
known
dna
fingerprint
compar
genom
microorgan
obtain
cultur
fingerprint
also
allow
speci
identif
importantli
facilit
identif
molecular
marker
associ
diseas
invok
potenti
given
strain
potenti
pathogen
microorgan
socal
pathotyp
import
recent
develop
avail
molecular
diagnost
initi
consid
panacea
replac
convent
test
detect
identif
microorgan
molecular
procedur
turn
slow
cautiou
process
howev
sever
innov
nucleic
acid
identif
test
current
beyond
slightli
ahead
breakthrough
clinic
relev
microorgan
one
molecular
test
detect
identif
even
speci
level
becom
avail
although
commerci
develop
test
sale
preval
infecti
diseas
agent
highthroughput
use
test
howev
becom
common
although
still
somewhat
restrict
larger
laboratori
possess
adequ
technic
equip
analyt
expertis
chapter
current
stateoftheart
molecular
diagnost
compar
genom
medic
microbiolog
describ
togeth
technolog
advanc
made
recent
addit
problem
remain
solv
prior
gener
accept
nucleic
acidmedi
detect
identif
microbi
pathogen
also
review
chapter
highlight
success
novel
applic
provid
exampl
modern
molecular
diagnost
approach
field
bacteri
infect
viral
diagnosi
discuss
depth
short
section
describ
current
state
affair
within
virolog
provid
later
chapter
essenti
molecular
diagnost
infecti
diseas
simpl
straightforward
clinic
sampl
yet
identifi
organ
deriv
microbiolog
cultur
experi
provid
use
broadspectrum
nucleic
acid
isol
procedur
gener
materi
includ
templat
nucleic
acid
hybrid
amplif
assay
reaction
proceed
posit
neg
result
produc
interpret
translat
diagnost
result
howev
simpl
scenario
compromis
varieti
obviou
emerg
problem
solv
remain
continu
investig
search
eleg
solut
exampl
recent
technolog
success
follow
past
decad
guanidinium
isothiocyan
celit
affin
procedur
accept
gold
standard
mani
molecular
diagnost
laboratori
boom
et
al
main
downsid
fact
manual
version
procedur
still
quit
timeconsum
labori
fortun
altern
system
becom
avail
extract
simplif
autom
progress
well
commerci
avail
handi
spin
column
assay
eg
qiagen
kit
mcorist
et
al
fulli
autom
nucleic
acid
isol
system
develop
autom
celit
affin
procedur
nuclisens
extractor
machin
roch
molecular
system
market
magnapur
dna
isol
robot
allow
parallel
dna
extract
hundr
sampl
per
work
day
invok
limit
handson
time
van
doornum
et
al
recent
studi
three
method
nuclisen
minimag
magna
pure
dna
isol
kit
iii
bacteriafungi
roch
silicaguanidiniumthiocyan
siguscnf
procedur
extract
dna
stool
specimen
compar
manual
siguscnf
procedur
show
highest
analyt
perform
lowest
associ
cost
per
extract
euro
howev
method
requir
longest
handson
time
minimag
magna
pure
extract
show
similar
perform
regard
amplif
inhibit
method
show
rel
low
rate
cost
final
euro
siguscn
euro
magna
pure
euro
minimag
schuurman
et
al
improv
nucleic
acid
yield
sampl
throughput
anticip
current
separ
dna
extract
amplif
machin
soon
combin
singl
apparatu
cockeril
smith
monitor
extract
process
loss
target
contamin
inhibitori
compound
intern
process
control
introduc
see
also
section
detail
methodolog
identifi
deleteri
effect
extract
loss
sampl
amplif
inhibit
enabl
one
confid
posit
neg
result
gener
state
molecular
microbiologist
put
enorm
effort
demonstr
efficaci
nucleic
acidmedi
test
past
year
far
classic
microbiolog
dnarna
test
subject
extrem
detail
stringent
intercent
qualiti
control
studi
interestingli
new
gener
test
withstood
comparison
classic
test
quit
easili
therebi
confirm
superior
wide
accept
classic
test
system
harmsen
et
al
niester
recent
molecular
diagnost
methicillin
resist
staphylococcu
aureu
mrsa
bacteria
also
subject
multicent
valid
studi
van
belkum
et
al
implement
pcr
amplif
test
routin
laboratori
requir
logist
adapt
train
program
personnel
involv
one
variou
stage
pcr
diagnost
ie
nucleic
acid
purif
prepar
enzym
master
mix
collat
complet
pcr
sampl
amplif
final
analysi
amplifi
materi
prefer
perform
physic
separ
laboratori
advis
even
plan
personnel
involv
downstream
manner
individu
contact
amplim
allow
enter
clean
laboratori
anymor
day
import
adapt
requir
prevent
contamin
subsequ
fals
posit
result
current
gener
commerci
assay
use
intellig
system
ung
glycosylas
approach
meier
et
al
result
prepcr
destruct
amplim
gener
prior
test
system
proven
quit
robust
ry
pers
sever
measur
precaut
taken
essenti
prevent
carryov
contamin
occur
replac
dnacontamin
dispos
articl
clean
one
avoid
pipett
abus
aerosol
format
adequ
rout
patient
materi
use
moleculargrad
pcr
ingredi
altern
option
comprehens
discuss
import
factor
recent
publish
millar
colleagu
initi
molecular
test
infecti
diseas
strictli
qualit
natur
provid
straightforward
yesorno
answer
question
relat
absenc
presenc
certain
pathogen
recent
improv
nucleic
acidmedi
technolog
quantit
aspect
also
becam
address
current
methodolog
allow
assess
rel
quantiti
given
nucleic
acid
target
molecul
clinic
sampl
barken
et
al
varieti
realtim
pcr
machin
develop
includ
among
other
geneamp
prism
appli
biosystem
biorad
icycl
roch
lightcycl
cepheid
smartcycl
genexpert
stratagen
rotor
gene
corbett
research
see
also
chapter
machin
share
high
assay
speed
minut
hour
per
run
suffici
sampl
capac
sampl
per
run
realtim
technolog
combin
pcr
taqman
hydrolysi
probe
lung
et
al
nasba
molecular
beacon
weusten
et
al
hybrid
probe
bidet
et
al
help
improv
tediou
process
realtim
detect
identif
well
establish
new
technolog
reproduc
abil
detect
small
amount
infecti
agent
sort
clinic
specimen
question
whether
nucleic
acid
quantif
may
ad
valu
clinic
infecti
diseas
manag
distinct
group
patient
must
answer
near
futur
main
issu
whether
larger
amount
pathogen
present
may
indic
sever
underli
diseas
case
suggest
virolog
studi
schutten
niester
impli
quantit
test
could
also
use
success
monitor
efficaci
treatment
protocol
case
speci
microbi
pathogen
capabl
invok
infecti
syndrom
may
larg
number
infect
lower
upper
airway
instanc
caus
varieti
bacteri
speci
includ
random
order
streptococcu
pneumonia
moraxella
catarrhali
haemophilu
influenza
bordetella
pertussi
mycoplasma
pneumonia
legionella
pneumophila
chlamydia
pneumonia
staphylococcu
aureu
klebsiella
pneumonia
other
cover
wide
varieti
virus
fungi
parasit
well
would
cost
effect
pathogen
involv
similar
clinic
manifest
diseas
could
detect
singl
assay
broad
spectrum
pcr
coupl
speciesspecif
nucleic
acid
probe
assay
could
provid
opportun
roth
et
al
wherea
multiplex
pcr
describ
capabl
achiev
similar
feat
ko
et
al
type
assay
becom
increasingli
import
come
year
especi
introduct
quantit
variant
test
downsid
multiplex
multiplex
pcr
usual
consid
less
sensit
simplex
approach
problem
could
circumv
appli
new
gener
pcrmediat
test
instanc
multiplex
ligat
probe
assay
suppos
rel
insensit
downsid
classic
pcr
multiplex
reijan
et
al
recent
test
describ
supposedli
detect
respiratori
virus
one
reaction
mlpa
reaction
preced
preamplif
step
ensur
detect
rna
dna
virus
specif
sensit
individu
monoplex
realtim
rtpcr
use
test
show
increas
diagnost
yield
compar
cell
cultur
test
provid
userfriendli
highthroughput
tool
simultan
detect
respiratori
virus
excel
overal
perform
statist
detect
illdefin
even
previous
unrecogn
bacteri
pathogen
pursu
broad
spectrum
pcr
method
alreadi
allud
previou
section
relman
method
usual
involv
pcr
target
univers
conserv
eubacteri
pcr
prime
site
wellknown
exampl
target
ribosom
gene
although
success
broad
spectrum
amplif
gene
encod
dna
polymeras
dna
gyras
protein
elong
factor
describ
well
broad
spectrum
pcr
recent
use
tri
resolv
varieti
clinic
syndrom
includ
instanc
periodont
diseas
kumar
et
al
nonchlamydi
nongonococc
urethr
men
riemersma
et
al
latter
studi
elegantli
demonstr
infecti
diseas
presenc
pathogen
may
import
also
absenc
certain
appar
healthi
compon
resid
flora
may
help
diagnos
diseas
may
howev
fundament
obstruct
diagnost
implement
broad
spectrum
pcr
instanc
intens
discuss
still
ongo
presenc
nativ
nonpathogen
commens
bacteria
human
blood
nikkari
et
al
mclaughlin
et
al
phenomena
may
end
complet
frustrat
applic
broad
spectrum
pcr
nucleic
acid
extract
matric
clinic
microbiolog
compani
focu
limit
number
econom
attract
microb
develop
wellstandard
commerci
avail
assay
perspect
deem
unlik
number
scope
activ
market
infecti
diseas
test
increas
rapidli
come
year
econom
interest
diagnost
area
seem
cover
primarili
competit
diagnost
compani
may
increas
significantli
differ
test
aim
agent
becom
wide
avail
howev
emphas
larg
still
grow
list
less
preval
microbi
pathogen
commerci
avail
nucleic
acid
test
system
would
much
appreci
medic
microbiologist
infecti
diseas
specialist
minor
pathogen
molecular
diagnostician
reli
test
develop
inhous
major
drawback
fact
test
gener
accept
wide
use
test
usual
suffer
restrict
qualiti
control
see
also
chapter
hope
small
nich
market
rais
interest
startup
small
compani
besid
current
lack
specif
test
avail
anoth
bottleneck
due
lack
conveni
reproduc
nucleic
acid
isol
system
use
combin
divers
clinic
specimen
receiv
clinic
microbiolog
laboratori
although
sever
open
system
avail
still
clear
need
versatil
highli
reliabl
autom
system
avail
machin
may
significantli
enhanc
full
implement
nucleic
acid
detect
daytoday
laboratori
set
furthermor
enabl
laboratori
gener
result
within
short
turnaround
time
essenti
infecti
diseas
manag
addit
limit
amount
inform
avail
dy
function
present
gener
robot
instrument
use
diagnost
analys
scant
avail
thu
far
frustrat
detail
intercent
comparison
machin
perform
interest
note
integr
platform
nucleic
acid
extract
amplif
avail
particularli
noteworthi
machin
even
consid
portabl
due
small
size
seme
et
al
lack
standard
qualiti
control
programm
anoth
persist
problem
area
molecular
diagnost
see
also
chapter
known
sinc
earli
one
signific
hurdl
overcom
molecular
technolog
fals
posit
due
contamin
fals
neg
due
larg
differ
sensit
variou
test
system
schuurman
et
al
european
intercent
qualiti
control
research
program
inde
shown
clear
need
standard
refer
materi
gener
desir
particip
qualiti
control
program
instanc
one
organ
qualiti
control
molecular
diagnost
qcmd
organ
van
vliet
et
al
van
belkum
et
al
latter
organ
initi
fund
european
union
provid
qualiti
control
scheme
increas
number
viral
bacteri
target
besid
need
welldefin
qualit
qualiti
control
program
also
lack
standard
semi
quantit
assay
extern
standard
develop
format
show
maximum
ident
sampl
interest
end
integr
molecular
standard
mayb
even
unit
definit
would
facilit
intercent
commun
match
data
conclus
still
present
absolut
quantif
hard
achiev
problem
may
persist
year
come
also
field
subspeci
identif
clinic
bacteri
isol
big
problem
note
mani
molecular
technolog
use
fingerprint
genom
microb
fail
reproduc
implement
even
differ
close
collabor
laboratori
van
belkum
et
al
van
belkum
et
al
although
incident
success
report
current
gold
standard
procedur
microbi
type
de
lencastr
et
al
murchan
et
al
technolog
like
surviv
end
alreadi
provid
use
tool
detail
intern
microbi
dissemin
studi
probabl
multilocu
sequenc
type
mlst
technolog
appli
use
affymetrix
dna
chip
technolog
well
maiden
et
al
van
leeuwen
et
al
addit
applic
bacteri
whole
genom
sequenc
form
deep
sequenc
becom
access
technolog
discuss
later
section
chapter
one
realiz
translat
experiment
research
tool
routin
molecular
diagnost
still
complet
mani
case
virolog
mainli
hamper
fact
mani
new
test
system
realli
new
histor
altern
sensit
detect
procedur
nonnucl
acid
methodolog
detect
hepat
viru
human
metapneumoviru
coronaviru
caus
sar
recent
exampl
su
et
al
poon
et
al
van
den
hoogen
et
al
render
compar
qualiti
assess
difficult
imposs
laboratori
scientist
clinician
need
put
trust
test
stand
larg
unverifi
howev
power
versatil
reliabl
nucleic
acid
test
alreadi
convinc
investig
clinic
respons
avail
unpreced
test
virolog
acceler
develop
process
qualiti
control
oberst
et
al
van
elden
et
al
zaaijer
et
al
one
mean
measur
valid
perform
diagnost
test
use
extern
qualiti
assess
eqa
control
program
qcmd
network
suppli
standard
refer
sampl
panel
use
monitor
develop
implement
nucleic
acid
detect
technolog
qualit
quantit
manner
valentinethon
et
al
wallac
use
eqa
recent
year
focus
almost
exclus
bloodborn
virus
standard
test
commerci
avail
howev
need
eqa
relat
larg
panel
clinic
relev
commerci
less
interest
target
grow
espi
et
al
savolainen
et
al
besid
extern
qualiti
control
virolog
also
excel
develop
intern
control
procedur
one
eleg
control
system
concern
complet
nonhuman
seal
herp
dna
viru
van
doornum
et
al
realtim
quantit
taqman
assay
develop
phocin
herp
viru
phhv
viru
grown
rel
easili
cell
cultur
henc
avail
sheer
unlimit
amount
also
univers
rna
viru
introduc
intern
control
phocin
distemp
viru
pdv
could
serv
purpos
phhv
exampl
revers
transcriptas
rt
pcr
applic
niester
assumpt
intact
viru
use
univers
intern
control
behav
similarli
extract
procedur
compar
target
virus
interest
contrast
use
exampl
plasmid
intern
control
low
fix
amount
viru
equal
amount
give
cutoff
ct
valu
realtim
assay
approxim
cycl
amplif
need
ad
clinic
sampl
extract
procedur
start
virolog
mostli
involv
serum
plasma
although
analysi
sputum
throat
sampl
also
success
intern
control
viru
genom
coextract
subsequ
amplifi
quantit
manner
current
separ
tube
protocol
molecular
diagnost
bacteriolog
start
purif
dna
rna
bacteria
involv
word
procedur
aim
detect
certain
specif
pathogen
adapt
simpli
detect
pathogen
gener
commerci
avail
molecular
procedur
suit
detect
sexual
transmit
intracellular
pathogen
chlamydia
trachomati
highlight
follow
page
addit
method
suit
detect
subspecif
identif
gramposit
microorgan
staphylococcu
aureu
often
base
inhous
test
discuss
detail
c
trachomati
microb
capabl
caus
two
major
clinic
syndrom
infect
eye
caus
trachoma
ultim
lead
blind
infect
fallopian
tube
caus
pelvic
inflammatori
diseas
pid
major
caus
infertil
women
review
see
schachter
clear
diagnosi
c
trachomati
infect
western
countri
usual
dissemin
sexual
contact
vertic
transmiss
birth
requir
prioriti
classic
c
trachomati
diagnosi
depend
organ
capabl
infect
certain
receptor
celllin
cervic
swab
taken
transport
laboratori
special
conserv
medium
suspect
materi
inocul
cell
cultur
system
appear
cytopathogen
effect
indic
presenc
c
trachomati
suchland
et
al
test
system
insensit
labori
expens
requir
high
level
analyt
expertis
henc
avail
initi
dna
hybridizationbas
cultur
confirm
test
spur
enthusiasm
diagnost
commun
tenov
addit
extend
cultur
diagnosi
first
direct
nucleic
acid
test
becam
avail
earli
last
centuri
commerci
test
manufactur
genprob
san
diego
ca
initi
aim
direct
ribosom
rna
detect
second
gener
test
also
abl
gener
limit
ribosom
rna
amplif
verkooyen
et
al
ultim
variou
amplif
mediat
test
develop
base
technolog
bacteriophag
qb
rna
polymeras
mediat
amplif
stefano
et
al
ligas
chain
reaction
lcr
blocker
et
al
cours
pcr
see
verkooyen
et
al
refer
therein
test
underw
extens
comparison
culturebas
assay
among
ultim
pcr
test
prevail
although
lcr
test
demonstr
adequ
sensit
specif
pannekoek
et
al
appar
prefer
mani
research
pcr
commerci
develop
took
variou
quantum
leap
roch
molecular
system
sell
integr
pcrbase
detect
system
call
coba
amplicor
system
facilit
autom
c
trachomati
diagnost
base
use
cervic
swab
also
less
invas
patientfriendli
urin
sampl
lesli
et
al
similarli
commerci
diagnost
system
develop
becton
dickinson
base
strand
displac
amplif
principl
introduc
found
versatil
reliabl
well
bang
et
al
cosentino
et
al
conclus
mere
year
drastic
diagnost
chang
observ
concern
detect
c
trachomati
cumbersom
cell
cultur
system
combin
cervic
swab
new
gold
standard
technolog
detect
c
trachomati
urin
perform
machin
gener
adequ
result
within
half
work
day
ad
increas
sensit
specif
test
system
speed
throughput
also
improv
significantli
past
decad
concis
metaanalysi
avail
data
see
tabl
although
detail
costeffect
studi
publish
thu
far
preliminari
explor
alreadi
indic
popul
preval
c
trachomati
infect
direct
cost
pcr
mediat
screen
program
low
compar
symptomdriven
analys
paavonen
et
al
recent
evalu
c
trachomati
test
pregnant
women
firstvoid
urin
specimen
consecut
asymptomat
pregnant
women
collect
rour
et
al
coba
amplicor
test
compar
coba
amplicor
test
prior
dna
isol
use
magna
pure
next
use
urin
coba
amplicor
perform
individu
test
compar
pool
test
standard
coba
amplicor
procedur
subsequ
pool
test
coba
amplicor
combin
magna
pure
bacteri
dna
isol
kit
sensit
coba
amplicor
individu
pool
urin
improv
pool
urin
magna
pure
bacteri
dna
isol
kit
make
combin
best
screen
method
c
trachomati
preval
popul
appear
addit
cost
combin
magna
pure
bacteri
dna
isol
kit
coba
amplicor
method
pool
urin
cost
standard
coba
amplicor
test
appli
individu
urin
cost
per
posit
case
detect
combin
method
standard
cost
noteworthi
molecular
test
c
trachomati
continu
surpris
scientif
commun
case
conjunct
directli
link
matern
carriag
rour
et
al
wherea
also
ongo
discuss
related
prematur
deliveri
c
trachomati
statu
caan
classic
aureu
cultur
still
amen
improv
novel
select
growth
media
provid
excel
yield
specif
still
strong
competitor
diagnost
dna
test
case
aureu
especi
detect
methicillinresist
version
aureu
mrsa
import
drive
factor
behind
diagnost
improv
colon
patient
medic
personnel
particularli
antibioticmultiresist
bug
predispos
danger
difficulttotreat
infect
colon
subsequ
infect
spread
mrsa
hospit
set
must
therefor
prevent
henc
continu
need
method
mrsa
detect
genet
identif
see
tabl
short
list
current
avail
method
mrsa
like
methicillinsuscept
aureu
mssa
prime
ecolog
nich
vestibulum
nasi
foremost
compart
nose
diagnost
procedur
often
focus
analysi
nasal
swab
exampl
recent
describ
new
medium
oxacillin
resist
screen
agar
develop
blanc
colleagu
medium
provid
adequ
result
within
hour
inocul
extens
comparison
culturebas
assay
recent
present
safdar
colleagu
compar
differ
media
conclus
optim
sampl
taken
standard
rayon
swab
materi
enrich
overnight
saltcontain
trypticas
soy
broth
preenrich
cultur
subsequ
inocul
lipovitellincontain
mannitol
salt
agar
contain
oxacillin
addit
oxacillin
disk
agar
surfac
increas
specif
shown
qualiti
clinic
specimen
one
prime
determin
diagnost
efficaci
instanc
nasal
swab
prefer
perian
throat
swab
assess
colon
statu
person
singh
et
al
howev
pcr
still
consid
futur
gold
standard
diagnost
tool
especi
detect
identif
mrsa
mani
aureu
pcr
test
one
way
anoth
includ
detect
methicillin
resist
gene
encod
penicillin
bind
protein
miyamoto
et
al
first
mecaspecif
test
publish
earli
murakami
et
al
mani
follow
past
decad
test
presenc
mrsa
clinic
import
instanc
hallin
colleagu
demonstr
pcr
diagnosi
instrument
modif
optim
antibiot
therapi
patient
includ
clinic
studi
also
among
cardiac
surgeri
patient
prevent
postsurg
aureu
wound
infect
better
guid
pcr
cultur
shrestha
et
al
besid
pcr
molecular
amplif
methodolog
also
appli
detect
aureu
new
method
isotherm
signal
amplif
isa
allow
detect
least
mrsa
cell
although
method
may
advantag
fact
gener
timeconsum
enrich
cultur
requir
prior
isa
may
ultim
signific
obstacl
latest
develop
realtim
quantit
pcr
borg
et
al
fang
hedin
gueudin
et
al
realtim
procedur
success
appli
infect
control
purpos
highthroughput
applic
facilit
spectacular
technolog
develop
boyc
et
al
gilpin
et
al
kluytman
mani
nucleic
acidcontrol
technolog
appli
order
reach
refin
molecular
diagnost
includ
genom
sequenc
computer
experiment
compar
genom
order
increas
number
adequ
target
sequenc
baba
et
al
recent
shown
whole
genom
sequenc
could
help
identifi
develop
mutat
staphylococc
genom
contribut
develop
vancomycin
resist
mwangi
et
al
tabl
exampl
mrsaspecif
test
system
four
categori
test
system
includ
complet
survey
meant
highlight
common
technolog
respect
perform
clinic
diagnost
bbl
crystal
mrsa
id
test
assess
viabil
mean
biochem
detect
oxygen
consumpt
fluoresc
compound
fluoresc
commerci
avail
multiwel
system
assess
growth
presenc
variou
antibiot
qadri
et
al
zambardi
et
al
kubina
et
al
soft
salt
mannitol
agar
cloxacillin
test
consist
tube
contain
medium
use
bedsid
direct
swab
inocul
indic
substanc
induc
color
chang
upon
presenc
mrsa
mir
et
al
chromagar
staph
aureu
oxa
resist
screen
agar
chromogen
plate
media
addit
render
media
suitabl
mrsa
identif
aureu
coloni
agar
show
distinct
purpl
color
chromagar
problem
note
test
sensit
merlino
et
al
apfalt
et
al
lipovitellin
salt
mannitol
agar
select
medium
lipovitellin
glycosyl
lipid
bind
protein
present
yolk
egg
lay
anim
show
homolog
human
apolipoprotein
b
growth
verghes
et
al
vitek
technolog
develop
biomerieux
repres
autom
biochem
antimicrobi
screen
bacteri
isol
biochem
antimicrobi
profil
produc
limit
handson
time
knapp
et
al
oxacillin
resist
screen
agar
anoth
chromogen
select
cultur
medium
blue
stain
coloni
requir
followup
identif
reaction
blanc
et
al
protein
detect
system
kilodalton
aureu
surfac
protein
found
use
agglutin
nonagglutin
strain
mrsa
experiment
setup
use
purifi
antibodi
react
protein
kuusela
et
al
mrsa
screen
facilit
detect
crude
cell
prepar
latex
agglutin
system
van
leeuwen
et
al
nucleic
acid
detect
system
evigen
probe
hybrid
use
nonpcrmedi
detect
mrsa
stain
spectrophotometri
nm
velogen
rapid
mrsa
identif
assay
probemedi
procedur
use
chimer
probe
cycl
mediat
recognit
meca
gene
combin
immunomagnet
enrich
aureu
follow
taqman
pcr
use
smartcycl
fluoresc
measur
use
smartcycl
hardand
softwar
francoi
et
al
taqman
pcr
aureu
nuc
gene
combin
select
culturebas
preenrich
fluoresc
measur
fang
hedin
studi
demonstr
sequenc
use
diagnost
also
epidemiolog
analys
forget
linkag
genom
flexibl
phenotyp
transcript
profil
use
dna
chip
use
enhanc
understand
stageor
stimulusspecif
gene
express
aureu
mongodin
et
al
addit
explor
human
genom
polymorph
associ
staphylococc
infect
carriag
could
end
gener
altern
strategi
identif
peopl
elev
risk
acquir
staphylococc
infect
van
belkum
et
al
b
van
den
akker
et
al
wertheim
et
al
import
new
featur
diagnosi
aureu
infect
possibl
simultan
detect
presenc
certain
virul
gene
instanc
french
studi
convincingli
show
presenc
gene
pantonvalentin
leukocidin
pvl
confer
strong
diseas
invok
capac
upon
staphylococcu
pvlposit
strain
implic
causal
agent
sever
case
necrot
pneumonia
diseas
lead
signific
mortal
gillet
et
al
addit
shown
dutch
research
group
presenc
one
virul
gene
may
lead
enhanc
impetigo
children
shown
presenc
exfoli
toxin
b
etb
gene
also
pvl
gene
led
increas
number
overal
size
impetigo
lesion
kone
et
al
avail
complet
inventori
put
virul
gene
base
whole
genom
comparison
possibl
predict
diagnosi
increas
futur
virul
gene
repertoir
colon
aureu
strain
assess
molecular
diagnost
depend
virul
gene
profil
may
decid
strain
need
elimin
prior
patient
undergo
surgic
treatment
reduc
risk
postsurg
wound
infect
final
detect
subspeci
genet
polymorph
import
fingerprint
staphylococc
isol
henc
facilit
epidemiolog
studi
dissemin
clone
mssa
mrsa
past
epidemiolog
studi
essenti
base
strain
antimicrobi
resist
profil
biochem
characterist
phage
type
weiss
nitzkin
phage
type
determin
strain
suscept
toward
infect
larg
panel
lytic
aureusspecif
bacteriophag
essenti
binari
code
develop
consist
altern
sensit
resist
toward
given
phage
weller
forti
year
ago
phage
type
epidemiolog
gold
standard
use
even
success
inform
nationwid
analysi
dissemin
ident
aureu
phagetyp
clonal
dissemin
reveal
interest
staphylococc
colon
infect
dynam
set
stage
develop
stabl
reproduc
type
system
molecular
microbiolog
provid
altern
possibl
phage
type
instanc
compar
detail
random
amplif
polymorph
dna
pcr
method
gener
dna
fingerprint
consist
nonidentifi
dna
molecul
van
belkum
et
al
show
dnamedi
procedur
better
sens
appear
reproduc
resolv
power
clearli
enhanc
past
year
rel
larg
set
altern
strategi
type
aureu
becom
avail
includ
assess
mutat
variabl
number
tandem
repeat
vntr
loci
sabat
et
al
method
aim
detect
unit
number
variat
certain
genet
loci
fastevolv
repetit
dna
mechan
behind
form
dna
polymorph
slip
strand
mispair
replic
dna
polymeras
skip
add
repeat
unit
consequ
complex
tertiari
structur
repetit
dna
domain
van
belkum
et
al
multilocu
analysi
socal
mlva
approach
develop
medic
relev
speci
aureu
multipl
system
describ
tenov
et
al
francoi
et
al
specif
mrsa
variou
method
finetyp
pbpencod
gene
neighbor
sequenc
develop
ito
et
al
oliveira
de
lencastr
method
usual
depend
select
pcrmediat
amplif
locusspecif
sequenc
element
see
fig
although
nearli
dna
type
method
appear
use
epidemiolog
analysi
mrsa
mssa
van
belkum
puls
field
gel
electrophoresi
stranden
et
al
multilocu
sequenc
type
mlst
feil
et
al
two
method
current
best
appreci
hundr
paper
publish
describ
use
pfge
epidemiolog
comparison
set
mrsa
mssa
strain
van
belkum
see
fig
exampl
research
effort
strongli
contribut
current
awar
natur
intern
mrsa
dissemin
air
de
sousa
de
lencastr
mlst
rel
new
defin
singl
nucleotid
polymorph
snp
housekeep
gene
gene
sequenc
translat
allel
code
accumul
gener
allel
lead
allel
profil
redefin
singl
digit
sequenc
type
st
resolv
power
strong
pfge
biggest
advantag
sequenc
data
extrem
portabl
data
put
singl
larg
databas
everi
individu
research
compar
strain
accord
mlst
type
databas
entri
facilit
worldwid
comparison
staphylococc
genotyp
made
number
realli
semin
studi
popul
structur
mrsa
mssa
recent
publish
day
et
al
fitzgerald
et
al
enright
et
al
feil
et
al
overal
five
six
major
mrsa
clone
travel
world
mani
minor
type
restrict
certain
locat
identifi
present
also
allel
variat
singl
staphylococc
gene
use
epidemiolog
trace
isol
within
speci
protein
aencod
spa
gene
contain
repeat
region
number
repeat
singl
variant
also
repeat
sequenc
vari
sequenc
basi
number
repeat
sequenc
ident
binari
code
attribut
strain
strommeng
et
al
method
highli
reproduc
air
de
sousa
et
al
alreadi
gener
massiv
amount
wellcommunic
data
dedic
websit
exist
spa
type
wide
advoc
tool
bring
nation
refer
center
closer
custom
also
colleagu
center
even
importantli
spa
type
suggest
first
system
could
possibl
facilit
realtim
type
clinic
set
mellmann
et
al
whether
true
fals
need
defin
wellcontrol
studi
still
nucleic
acidbas
test
introduc
increas
speed
routin
clinic
microbiolog
laboratori
check
part
initi
obviou
delay
due
inadequ
perceiv
prejud
shortcom
nucleic
acid
test
suppos
labori
expens
requir
high
level
laboratori
expertis
vaneechoutt
van
elder
howev
histor
object
slowli
taken
apart
acceler
introduct
molecular
diagnost
pursu
mani
case
pcr
test
legionalla
pneumophila
agent
legionnair
diseas
instanc
sensit
specif
improv
significantli
cultur
sensit
specif
urin
antigen
test
sensit
specif
murdoch
true
trichomona
vaginali
exampl
sexual
transmit
parasit
sever
pcr
test
show
increas
sensit
excel
specif
describ
van
der
schee
et
al
even
use
urin
instead
invas
swab
clinic
specimen
test
implement
immedi
massiv
clinic
microbiolog
frequent
perceiv
comment
respect
still
concern
suppos
level
complex
elev
cost
molecular
test
becom
clear
cost
effect
molecular
technolog
addit
regularli
shown
clear
improv
sensit
specif
clinic
test
achiev
introduc
molecular
test
swift
introduct
test
clinic
practic
remain
import
pursu
anoth
import
futur
applic
molecular
test
realm
host
suscept
toward
infect
relman
genet
profil
test
human
becom
wide
avail
implic
better
understood
infecti
diseas
specialist
ultim
profit
new
molecular
servic
mani
exampl
gene
import
host
defens
infect
describ
alreadi
santo
et
al
levequ
et
al
mani
mani
interest
see
excit
develop
lead
come
decad
whether
type
genet
data
ultim
collect
everi
individu
alreadi
matter
intens
ethic
debat
anticip
certain
diseas
identif
host
suscept
factor
eventu
replac
microbi
diagnost
genom
proteom
forget
metabolom
transcriptom
omic
scienc
start
domin
microbiolog
field
past
five
year
avail
complet
genom
sequenc
bacteria
larger
virus
open
new
avenu
fundament
appli
research
cum
et
al
diagnost
perspect
genom
facilit
character
novel
diagnost
epidemiolog
intrigu
target
sequenc
wherea
proteom
facilit
identif
complet
protein
profil
express
pathogen
differ
environment
condit
use
highthroughput
omic
method
enhanc
understand
infecti
diseas
figur
gel
electrophoret
analysi
genet
divers
presenc
methicillin
resist
gene
strain
staphylococcu
aureu
fingerprint
gener
puls
field
gel
electrophoresi
pfge
dna
macrorestrict
fragment
four
differ
characterist
band
pattern
observ
indic
letter
respect
lane
serv
purpos
unequivoc
determin
related
strain
lane
mark
contain
concatemer
phage
lambda
genom
smallest
one
bp
size
b
pcr
amplif
part
meca
gene
gene
encod
penicillin
bind
protein
product
show
diminish
affin
toward
antibiot
henc
causal
involv
resist
three
posit
reaction
observ
mark
asterisk
significantli
emphasi
come
year
function
omic
approach
microbiolog
omic
data
link
microbi
phenotyp
featur
host
pathogen
interact
need
emphas
principl
issu
cover
chapter
specif
pathogen
extrapol
speci
isol
everi
microbi
infecti
diseas
agent
exemplifi
beauti
molecular
diagnost
focus
nearli
univers
applic
technolog
suit
detect
pathogen
subsequ
genet
profil
pathogen
assess
virul
potenti
enabl
technolog
moreov
homolog
technolog
also
use
measur
host
respons
eventu
predict
host
suscept
toward
infecti
diseas
good
wit
obviou
system
biolog
approach
emerg
upon
introduct
new
tool
microbiolog
laboratori
outcom
molecular
diagnost
studi
continu
improv
understand
infecti
diseas
come
year
excit
time
